Glaukos Investor Relations Material
Latest events
Q4 2024
Glaukos
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Glaukos Corporation
Access all reports
Glaukos Corporation is a clinical-stage medical device company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment and management of glaucoma, corneal disorders and retinal diseases.
Key slides for Glaukos Corporation
43rd Annual J.P. Morgan Healthcare Conference 2025
Glaukos Corporation
43rd Annual J.P. Morgan Healthcare Conference 2025
Glaukos Corporation
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
GKOS
Country
🇺🇸 United States